Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WK1M
|
|||
| Drug Name |
Baltaleucel-T
|
|||
| Indication | Diffuse large B-cell lymphoma [ICD-11: 2A81; ICD-10: C83.3; ICD-9: 200] | Phase 2 | [1] | |
| Hodgkin lymphoma [ICD-11: 2B30; ICD-10: C81, C81.9] | Phase 2 | [1] | ||
| Lymphoma [ICD-11: 2A80-2A86; ICD-9: 202.8, 208.9] | Phase 2 | [1] | ||
| Post-transplant lymphoproliferative disorder [ICD-11: 2B32; ICD-10: D47.Z1; ICD-9: 238.77] | Phase 2 | [1] | ||
| Company |
Cell Medica Houston, TX
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | T-cells (T-cells) | Target Info | Immunomodulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.